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Identification of the Active Form of Endothelial Lipase, a Homodimer in a
Head-to-Tail Conformation
Abstract
Endothelial lipase (EL) is a member of a subfamily of lipases that act on triglycerides and phospholipids in
plasma lipoproteins, which also includes lipoprotein lipase and hepatic lipase. EL has a tropism for high
density lipoprotein, and its level of phospholipase activity is similar to its level of triglyceride lipase activity.
Inhibition or loss-of-function of EL in mice results in an increase in high density lipoprotein cholesterol,
making it a potential therapeutic target. Although hepatic lipase and lipoprotein lipase have been shown to
function as homodimers, the active form of EL is not known. In these studies, the size and conformation of
the active form of EL were determined. Immunoprecipitation experiments suggested oligomerization.
Ultracentrifugation experiments showed that the active form of EL had a molecular weight higher than the
molecular weight of a simple monomer but less than a dimer. A construct encoding a covalent head-to-tail
homodimer of EL (EL-EL) was expressed and had similar lipolytic activity to EL. The functional molecular
weights determined by radiation inactivation were similar for EL and the covalent homodimer EL-EL. We
previously showed that EL could be cleaved by proprotein convertases, such as PC5, resulting in loss of
activity. In cells overexpressing PC5, the covalent homodimeric EL-EL appeared to be more stable, with
reduced cleavage and conserved lipolytic activity. A comparative model obtained using other lipase structures
suggests a structure for the head-to-tail EL homodimer that is consistent with the experimental findings.
These data confirm the hypothesis that EL is active as a homodimer in head-to-tail conformation.
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Endothelial lipase (EL) is a member of a subfamily of lipases
that act on triglycerides and phospholipids in plasma lipopro-
teins, which also includes lipoprotein lipase and hepatic lipase.
EL has a tropism for high density lipoprotein, and its level of
phospholipase activity is similar to its level of triglyceride lipase
activity. Inhibition or loss-of-function of EL inmice results in an
increase in high density lipoprotein cholesterol, making it a
potential therapeutic target. Although hepatic lipase and
lipoprotein lipase have been shown to function as homodimers,
the active form of EL is not known. In these studies, the size and
conformation of the active form of EL were determined. Immu-
noprecipitation experiments suggested oligomerization. Ultra-
centrifugation experiments showed that the active form of EL
had a molecular weight higher than the molecular weight of a
simple monomer but less than a dimer. A construct encoding a
covalent head-to-tail homodimer of EL (EL-EL) was expressed
and had similar lipolytic activity to EL. The functional molec-
ular weights determined by radiation inactivation were simi-
lar for EL and the covalent homodimer EL-EL. We previously
showed that EL could be cleaved by proprotein convertases,
such as PC5, resulting in loss of activity. In cells overexpress-
ing PC5, the covalent homodimeric EL-EL appeared to be
more stable, with reduced cleavage and conserved lipolytic
activity. A comparative model obtained using other lipase
structures suggests a structure for the head-to-tail EL
homodimer that is consistent with the experimental findings.
These data confirm the hypothesis that EL is active as a
homodimer in head-to-tail conformation.
Three members of the triglyceride lipase family, lipoprotein
lipase (LPL),3 hepatic lipase (HL), and endothelial lipase (EL),
contribute to lipoprotein catabolism in the plasma compart-
ment. They are all secreted proteins that bind to heparan sulfate
proteoglycans on the luminal side of endothelial cells where
they interact with their lipoprotein substrates. They have dif-
ferent specificities for lipoproteins, and all hydrolyze triglycer-
ides and phosphatidylcholine at the sn-1 position, albeit with
widely differing efficiencies (1). The preferred lipoprotein sub-
strates for LPL are the triglyceride-rich lipoproteins, chylomi-
crons, and very low density lipoproteins; the triglyceride lipase
activity of LPL is more than 100-fold greater than its phospho-
lipase activity. The primary lipoprotein substrates for HL are
chylomicron remnants, intermediate density lipoproteins, and
large triglyceridase-enriched HDL; its triglyceride lipase activ-
ity is about 20-fold higher than its phospholipase activity. EL is
much more active on HDL, and its phospholipase activity is
quite similar to its triglyceride lipase activity.
These three lipolytic enzymes share a number of structural
features. By analogy to the crystal structure of pancreatic lipase
(2), anothermember of the triglyceride lipase family, each has a
clearly defined N-terminal and C-terminal structural domain,
joined by a hinge region. They are all serine esterases with a
catalytic triad of serine, aspartic acid, and histidine located in
the N-terminal domain. The catalytic triad is covered by a lid
domain that contributes to the preference for either triglycer-
ide or phospholipid substrates (3–6). The C-terminal domain
contributes to lipid binding and determines the preferences for
binding to lipoproteins (7–12). The N-terminal portion of the
EL molecule contains the active site of the enzyme. However,
when this portion of the molecule is expressed without the
C-terminal domain, it lacks enzymatic activity against phos-
pholipid (13), triglyceride, and the more soluble micellar sub-
strate tributyrin.4 Thus, the presence of the C-terminal domain
is necessary for activity. All three enzymes are glycosylated to
varying degrees, and two of the glycosylation sites (one each in
the N- and C-terminal domains) are common to all three
enzymes (14, 15). All three enzymes are also heparin-binding
proteins, and regions that contribute to heparin binding are
found in both the N- and C-terminal domains (16–18).
EL and, to a lesser extent, LPL are subject to proteolytic
cleavage by proprotein convertases at a prototypical RXKR site
in the hinge region, but HL lacks the site and is not cleaved (19,
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20). The catalytically active forms of both LPL and HL have
been shown to be homodimers (18, 21–27), and in the case of
LPL, the orientation of the subunits of the dimer has been
shown to be head-to-tail (28–30). The present study tested the
hypothesis that EL also functions as a head-to-tail dimer.
EXPERIMENTAL PROCEDURES
Construction of a Head-to-Tail Dimer of EL (EL-EL)—We
used PCR to engineer a head-to-tail dimer of two monomeric
subunits of EL (EL-EL) in an approach similar to that of Wong
et al. (28) for LPL using the same short hinge of 8 amino acids
(GSIEGRLE) to create the head-to-tail dimer of EL (Fig. 1).
Two cDNAs of human EL were amplified separately by
PCR. Each cDNA contained engineered restriction sites to
facilitate assembly and subcloning into the expression plas-
mid pcDNA3.1/myc-His()A (Invitrogen). The sense primer
of the first cDNA of EL (5-ACGTTCTAGAGGCAGGATGA-
GCAACTCCG-3) contained an XbaI restriction site and the
first 13 coding nucleotides of the EL cDNA. The antisense
primer of the first cDNA of EL (5-CGCTCTCGAGACGAC-
CTTCGATGGATCCGGGAAGCTCCACAGTGGGAC-3)
contained the last 20 coding nucleotides of the EL cDNA, a
factor Xa site (coding for 8 amino acids, GSIEGRLE), and an
XhoI restriction site. The sense primer of the second cDNA of
EL (5-GCGTCTCGAGAGCCCCGTACCTTTTGGTC-3)
contained anXhoI restriction site and the first 19 coding nucle-
otides of the mature EL protein. The antisense primer of the
second cDNA of EL (5-TGACAAGCTTTCAGGGAAGCTC-
CACAGTGGGAC-3) contained the last 23 coding nucleotides
of the EL cDNA and a HindIII restriction site. These two PCR
products were purified, digested using XbaI, XhoI, and HindIII
restriction enzymes, and then ligated using T4 ligase from a
rapid ligation kit (Roche Applied Science). The final product
contained sequences coding for the signal peptide of EL, the
mature EL protein, an 8-amino acid-peptide linker containing a
factor Xa site, and another mature EL protein (Fig. 1). To allow
comparison of the levels of expression of the dimeric construct
(EL-EL) andwild-type EL,we constructedC-terminalmyc-His-
tagged proteins by inserting the full-length cDNA into
pcDNA3.1/myc-His()A plasmid expression vector (Invitro-
gen). The construct was sequenced to confirm accuracy.
Cell Culture and Transfections—HEK293 cells and sublines
stably expressing profurin or PC5a weremaintained in Dulbec-
co’s modified Eagle’s medium, 10% fetal bovine serum, and 1
antibiotic/antimycotic supplement (Invitrogen). The cells were
transfected with EL constructs using LipofectamineTM reagent
(Invitrogen). Twenty four h after transfection, the mediumwas
replaced with Dulbecco’s modified Eagle’s medium containing
10 units/ml heparin (Sigma) and incubated for another 24 h.
Thirty min prior to harvesting this conditioned medium, more
heparin was added to the medium, bringing the final concen-
tration of heparin to 20 units/ml. Conditioned media were col-
lected, subjected to low speed centrifugation, and frozen in ali-
quots at 80 °C. For some experiments where high enzyme
activity was required (sucrose gradients and radiation inactiva-
tion), the conditioned medium was concentrated 5-fold using
an Amicon ultracentrifugal filtration device (30,000Mr cutoff)
(Millipore).
Western Blotting—The levels of protein expression of wild-
type EL and EL-EL were estimated by Western blot. For each
experiment, we used conditioned medium from cells trans-
fected to express green fluorescent protein (GFP) as a negative
control. Ten l of conditioned media were resolved on 10%
BisTris or 7% Tris acetate SDS-PAGE (Invitrogen) and trans-
ferred to Hybond ECL nitrocellulose membrane (Amersham
Biosciences). Proteins were detected using either a polyclonal
rabbit anti-human EL primary antibody specific for a peptide in
the N-terminal region or a monoclonal mouse anti-Myc pri-
mary antibody (clone 9E10) and a horseradish peroxidase-con-
jugated secondary antibody (Jackson ImmunoResearch).
Co-immunoprecipitation—Conditioned media from HEK293
cells transfectedwithGFP and co-transfectedwith EL-myc-His
and EL-FLAG or a 1:1 mixture of media from HEK293 cells,
which had been transfected with EL-myc-His or EL-FLAG,
were incubated with mouse (or rabbit) anti-Myc (Abcam) or
mouse anti-FLAG IgG (Sigma) at 4 °C in the presence of 0.1%
Triton X-100 (Fisher) for 2 h. Protein G magnetic beads (New
England Biolabs) were added to each sample, and samples were
incubated overnight at 4 °C. Supernatant and pellet were sepa-
rated after centrifuging for 10 min at 10,000  g, 4 °C. Pellets
were washed three times with phosphate-buffered saline and
eluted from the beads with 4 loading buffer and 10 dithio-
threitol (Invitrogen).Western blot analysis of samples was per-
formed using a rabbit anti-EL antibody or a rabbit anti-Myc
(Biovision) or a mouse anti-FLAG antibody (HRP conjugate,
Sigma).
Sucrose Gradient Ultracentrifugation—Sucrose gradients were
prepared as described (27). Briefly, 5–20% sucrose gradients
containing 50 mM ammonium hydroxide, pH 8.1, were pre-
pared. Glucose-6-phosphate dehydrogenase (G6PDH) (110
kDa) was added to each sample to serve as an internal standard.
Cytochrome c (12.5 kDa), ovalbumin (45 kDa),malate dehydro-
genase (74 kDa), and catalase (240 kDa)were centrifuged in two
separate tubes and served as external standards. After centrif-
ugation (22 h at 200,000  g at 4 °C), 600-l fractions were
collected and assayed for enzyme activity and protein concen-
tration. The protein concentration was determined in each
fraction of external standards using a commercially available kit
(BCA protein assay kit, Pierce).
FIGURE 1. Schematic diagram of EL-EL construct. Shown is a schematic
diagram representing EL-EL, the homodimer of EL in a head-to-tail conforma-
tion. A short hinge (linker) of 8 amino acid residues (GSIEGRLE) joined the two
monomeric subunits of EL using overlap extension PCR. EL-EL contained
sequences coding for the signal peptide (SP) of EL, themature EL protein, the
8aminoacid-peptide linker containinga factorXa site, andanothermature EL
protein. Each monomeric subunit of mature EL protein has an N-terminal
domain (N) and a C-terminal domain (C). To allow comparison of the levels of
expression of the dimeric construct (EL-EL) and wild-type EL, we constructed
C-terminal myc-His-tagged proteins.
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Radiation Inactivation—Conditioned medium containing
partially cleaved myc-His-tagged EL was prepared by transfec-
tion in HEK293 cells as described above. Media containing
either uncleaved myc-His-tagged wild-type EL or uncleaved
myc-His-tagged EL-EL dimer were prepared in a similar man-
ner by transfection inHEK293 cells that stably express profurin.
Apotransferrin (2 mg/ml, Sigma) and G6PDH (4 units/ml,
Sigma) were added to the media. Samples of these media (0.55
ml) were placed in glass vials, quick frozen, sealed, and stored at
80 °C. Vials were shipped and returned on dry ice. Irradia-
tions were performed with a linear electron accelerator at the
Armed Forces Radiobiology Research Institute, Bethesda, or at
the National Institute of Standards and Technology, Gaithers-
burg, MD. Frozen samples were irradiated at 135 °C with a
beam of 13-MeV electrons as described (31). Two aliquots not
irradiated served as the zero dose controls. Radiation dose was
determined with thermoluminescent or alanine dosimeters.
Irradiated frozen samples were stored at 80 °C until assayed
for triglyceride lipase activity. The activity (A) at each dose was
divided by the activity at zero dose (A0) to determine the frac-
tional residual activity at each dose. For each enzyme prepara-
tion, the natural logarithm of the fraction remaining was plot-
ted as a function of radiation dose. The slopes of these lines
were determined by linear regression (GraphPad Prizm) and
were used to calculate molecular mass as described previously
(31). The slopes for the inactivation ofG6PDHwere identical in
all sample sets.
Triglyceride Lipase and Phospholipase Assays—Emulsions of
triolein or dipalmitoylphosphatidylcholine were used to meas-
ure triglyceride lipase or phospholipase activity, respectively (1,
32, 33). For the triglyceride lipase assay, the emulsion contained
triolein and egg phosphatidylcholine containing glycerol
tri[9,10-3H]oleate stabilized with glycerol. For the phospho-
lipase assay, a similar glycerol-stabilized emulsionwas used that
contained radiolabeled phospholipids ([14C]dipalmitoylphos-
phatidylcholine) and cholesteryl oleate as the neutral lipid core.
Samples were incubated for 15 min at 37 °C. All enzyme activ-
ities are reported as nanomoles of free fatty acid liberated/h-ml
conditionedmedium as source of enzyme. All assays were done
in triplicate.
Other Enzyme Assays—Malate dehydrogenase activity was
measured by incubating 2 l of sample with 294 l of substrate
made of 367.4 M oxaloacetate and 204 M NADH in 40 mM
Tris-H2SO4, pH 7.4, at 25 °C. The decrease in absorbance was
monitored at 340 nm. G6PDH activity was measured by incu-
bating 5 l of sample in a final volume of 200 l containing 50
mM Tris-HCl, pH 7.8, 3 mMMgCl2, 0.2 mMNADP, and 3.3 mM
glucose 6-phosphate for 15 min at 25 °C and monitoring the
increase in absorbance at 340 nm.
Comparative Protein Structure Modeling Methods—The
human EL models were generated using the molecular model-
ing suite MODELLER version 8v1 (Accelrys Discovery Studio,
San Diego) and evaluated with MODELLER versions 8v1 and
9v1 (34–37). As input for the modeling algorithm, the human
EL protein sequence, NCBI protein data base accession code
NP_006024.1, was aligned to the following lipase structures
obtained from the Protein Data Bank: Homo sapiens pancre-
atic lipase and Sus scrofa co-lipase complex (PDB accession
code 1N8S), H. sapiens pancreatic lipase and S. scrofa co-
lipase complex inhibited by undecane phosphonate methyl
ester (PDB accession code 1LPB), and Equus caballus pan-
creatic lipase (PDB accession code 1HPL). Multiple
sequence alignments with the human EL protein sequence
and those of the aforementioned three protein structures
were generated by ClustalW (EMBL-EBI) using default
parameter settings (38). The human EL sequence has 27%
identity to human pancreatic lipase and 25% identity to
horse pancreatic lipase. These identical residues located
throughout the crystal structures of the pancreatic lipases
served as anchors to guide the modeling of human endothe-
lial lipase. The EL sequence contains 37 residues at the C ter-
minus thatwere not used in themodeling process because there
is no significant sequence homology to the other template
lipase structures in this region. The human EL models were
evaluated using the discrete optimized protein energy algo-
rithms of MODELLER version 9v1 (39). To investigate the
model structure in the context of a homodimer, the best scoring
human endothelial lipase monomer models were structurally
aligned to each monomer of the horse pancreatic lipase
homodimer using MacPyMOL version 0.96.
RESULTS
EL Is a Dimer That Forms Intracellularly—To understand
the intermolecular interaction of EL, we used two EL con-
structs, one encoding a FLAG tag and the other amyc-His tag at
the C terminus. Neither tag had any effect on EL lipolytic activ-
ity (data not shown). Constructs encoding EL-myc-His and EL-
FLAG were co-transfected in HEK293 cells. Conditioned
medium was harvested and subjected to immunoprecipitation
using an anti-Myc antibody to precipitate any Myc-containing
proteins. The precipitated proteins were examined byWestern
blotting using an anti-FLAGantibody aswell as an anti-EL anti-
body specific for a peptide in the N-terminal domain. No
immunoreactive bands were detected in conditioned medium
from cells transfected with a construct encoding GFP. As
shown in Fig. 2, when constructs encoding EL-myc-His and
EL-FLAG were co-transfected in HEK293 cells, the anti-FLAG
antibody detected FLAG-tagged EL in the material that had
been immunoprecipitated with anti-Myc antibody, indicating
that there was interaction between EL-FLAG and EL-myc-His
proteins, consistent with dimer formation. When conditioned
medium containing EL-FLAG was mixed with conditioned
medium containing EL-myc-His and subsequently immuno-
precipitated, no interaction was detected, suggesting that the
association between monomeric units occurs intracellularly
and that the association between subunits is very strong.
Active EL Is Larger than a Monomer and Consistent with
Partially Cleaved Dimer—Sucrose gradient centrifugation of
conditioned medium from cells expressing wild-type EL was
used to determine the size of the functional unit of EL. The
major peak of the triglyceride lipase activity of EL appeared as a
distinct species somewhat smaller than G6PDH (which has a
molecular weight of 110,000) as shown in Fig. 3A. A linear rela-
tionship was observed when the molecular weights of standard
proteins versus sucrose concentrations were plotted (Fig. 3B).
The relative molecular weight of the EL functional unit was
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94,500, considerably smaller than a dimer of full-length mono-
mers (136 kDa) and larger than amonomer (68 kDa). This func-
tional size ismost consistent with partially cleaved formswhere
part of the cleaved monomer remains associated with an
uncleaved monomer (Fig. 4A).
A Covalent Head-to-Tail EL Dimer Is Highly Active—We
engineered a construct encoding a covalent head-to-tail dimer
of two monomeric subunits of EL (EL-EL) joined by a short
hinge of eight amino acid residues (GSIEGRLE) using an
approach similar to that of Wong et al. (28) for LPL. The final
cDNA product contained sequences coding for the signal pep-
tide of EL, the mature EL protein, the 8-amino acid peptide
linker followed by anothermature EL protein, and a C-terminal
myc-His tag (Fig. 1). The expression of the dimeric construct
(EL-EL) was compared with wild-type EL, which was also myc-
His-tagged. Western blots of conditioned media of transiently
transfectedHEK293 cells using an antibody against theMyc tag
as primary antibody (Fig. 4B) showed a band corresponding to a
full-length monomer (68 kDa) in the case of wild-type EL and a
dimer (136 kDa) in the case of EL-EL, as well as the cleavage
products that are myc-His-tagged. Although dimeric forms are
not always present inWestern blots for wild-type EL, a dimeric
form and partially cleaved dimer are also visible in thewild-type
EL lane. In the Western blot of the same media using an anti-
body against EL as primary antibody (Fig. 4C), we observed the
full-length monomer of wild-type EL (68 kDa) and the full-
length dimer of EL-EL (136 kDa), and as expected some cleav-
age products (20). Interestingly, in the case of EL-EL we
detected cleavage products of intermediate size between a
monomer and a dimer corresponding to a monomer plus the
N-terminal domain (108 kDa) and a monomer plus the C-ter-
minal domain (96 kDa).
We compared the enzymatic activity of wild-type EL and
EL-EL using lipid emulsions of triglyceride and phospholipid to
measure triglyceride lipase and phospholipase activity, respec-
tively. The EL-EL dimer showed both triglyceride lipase and
phospholipase activities. For each transfection, we consistently
measured more lipase activity (both triglyceride lipase and
phospholipase) in EL-EL despite the protein band in the respec-
tive Western blot often appearing of similar or lesser intensity
than the band of the full-lengthwild-type EL (Fig. 4B). The ratio
of the triglyceride lipase activity to phospholipase activity (trig-
lyceridase/phospholipase ratio) reflects the substrate specific-
ity of the enzyme and was not significantly different for EL-EL
(1.46 0.57) than for EL (1.56 0.24). Thus the EL protein in
a dimeric head-to-tail conformation (EL-EL) was active both as
a triglyceride lipase and phospholipase. These data are consist-
ent with a model that EL is active as dimer in a head-to-tail
conformation.
Intermediate Oligomeric Forms of
EL Are Enzymatically Active—EL is
active as a dimer in a head-to-tail
conformation, but other intermedi-
ate forms could potentially also be
active provided that an intact active
site is present and preserved. To test
that hypothesis, we expressed wild-
type EL and EL-EL in HEK293 cells
under conditions promoting differ-
ent levels of cleavage. We used
HEK293 cells stably expressing pro-
furin, which has been reported to
prevent EL cleavage, or expressing
PC5a which has been reported to
fully cleave EL (20). Fig. 5 shows that
indeed more full-length EL and
EL-EL dimer were present in the
FIGURE 2. EL protein forms immunoprecipitable complex during secre-
tion but not after secretion. HEK293 conditioned media were prepared as
follows. Lanes 1 and 4 are fromcells expressingGFP; lanes 2 and 5 aremixtures
ofmedia from cells separately transfectedwith either EL-myc-His or EL-FLAG;
lanes 3, 6, and 7 are media from cells co-transfected with EL-myc-His and
EL-FLAG.Western blots (WB) show supernatants (lanes 1–3) and pellets (lanes
4–6) after immunoprecipitation (IP) with mouse anti-Myc from samples as
indicated. Lane 7 shows the pellet after immunoprecipitation with mouse
anti-FLAG from conditioned media from HEK293 cells co-transfected with
EL-myc-His and EL-FLAG. These Western blots used either an antibody
against an EL peptide, FLAG tag, or Myc tag for detection. F indicates the
full-length monomer size of EL; N indicates the N-terminal domain of EL, and
C indicates the C-terminal domain of EL.
FIGURE 3.A, sucrose gradient centrifugation ofwild-type EL. After 5–20% sucrose gradient ultracentrifugation,
samples were collected. Each fraction was tested for TG lipase activity () and G6PDH activity (f). The per-
centage of sucrose was also measured in each fraction collected. B, molecular weight of wild-type EL deter-
mined by ultracentrifugation. Themolecular standards used in this experiment were cytochrome c (12.5 kDa),
ovalbumin (45 kDa), malate dehydrogenase (74 kDa), G6PDH (114 kDa), and catalase (240 kDa). After centrifu-
gation (22 h at 200,000  g at 4 °C), fractions were collected and assayed for enzyme activity and protein
concentration. There is a linear relationship between the molecular weights of standard proteins and the
sucrose percentage.
Endothelial Lipase Functions as a Head-to-Tail Dimer
AUGUST 28, 2009•VOLUME 284•NUMBER 35 JOURNAL OF BIOLOGICAL CHEMISTRY 23325
 by guest on June 12, 2016
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
media of cells expressing profurin, whereas wild-type EL and
EL-EL dimerweremore heavily cleaved in the presence of PC5a
expression. Interestingly, EL-EL appeared more resistant to
cleavage in HEK293 cells and in the
absence or presence of PC5a in
comparison with wild-type EL.
These data support the concept that
the oligomeric state of EL is dimeric
and that the linker hinge in the EL-EL
protein stabilizes the enzyme,making
it less prone to inactivating enzymatic
cleavage by enzymes of the propro-
tein convertase family such as PC5a.
The linker hinge also ensures that the
N-terminal and C-terminal domains
remain attached andpresumably pre-
serve an active site.
We measured the triglyceride
lipase and phospholipase activity of
wild-typeELandEL-EL in these three
experimental conditions (Table 1). In
the case of EL, both the triglyceride
lipase and phospholipase activity of
wild-typeELdecreasedas theamount
of cleavage increased (Fig. 5 andTable
1). Similar results were observed in
the case of EL-EL, where both the
triglyceride lipase and phospho-
lipase activity of EL-EL decreased as
the amount of cleavage increased (Fig. 5 and Table 1). EL-EL
differed from wild-type EL only in the extent of the effect.
Indeed, EL-EL only partially lost activity in the presence of
PC5a, whereas wild-type EL was more drastically affected. Our
activity data (triglyceride lipase and phospholipase) associated
with the mass indicated that as less protein was cleaved in the
case of EL-EL comparedwithwild-type EL,more lipolytic enzy-
matic activity remained (Fig. 5 and Table 1). These data indi-
cated that not only is EL active as a homodimer but that the
cleavage of EL results in a loss of activity and the partially or
wholly cleaved forms of EL are less active or inactive.
Comparison of the Molecular Mass of Uncleaved Wild-type
EL and Uncleaved Dimeric EL—The functional size of EL was
examined using radiation inactivation. Conditioned medium
was prepared from cells expressing myc-His-tagged wild-type
EL that was partially cleaved. The same construct was trans-
fected in cells expressing profurin to produce EL that was
uncleaved, as was the myc-His-tagged head-to-tail construct
EL-EL, to produce the covalently linked dimer, also uncleaved.
As shown in Fig. 6, all three preparations gave single exponen-
tial decays as a function of radiation dose. Unlike the sucrose
density analysis, radiation inactivation is not influenced by gly-
cosylation. The inactivation is a function only of the protein
component of the enzyme. The predicted protein mass of a
dimer of wild-type EL is 109,201 Da and of the dimer with the
covalent linker is 110,061 Da. Both of the uncleaved prepara-
tions gave highly similar decay functions, which indicated a
functional molecular mass of protein of 103.3 kDa for the
uncleaved wild-type EL and 108.5 kDa for the uncleaved dimer
that contains the additional 8-amino acid linker. Thus we can
conclude that EL functions as a head-to-tail homodimer. The
wild-type EL that had undergone cleavage also gave a single
FIGURE 4.A, cleavage products of ELmonomer and EL dimer. A schematic diagram is shownof all the potential
intermediate forms of EL monomer and EL dimer induced by the proteolytic cleavage of EL by proprotein
convertases. All the possible forms varying from uncleaved to partially cleaved and fully cleaved in the case of
ELmonomer and EL dimer are represented. The relativemolecularmass of each of these forms in kDa is shown.
B, Western blot of EL and EL-EL detected by an antibody against Myc tag. Expression in HEK293 conditioned
mediaofMyc-taggedELandEL-ELwasdetectedbyWesternblotusingamouseanti-Mycmonoclonal antibody
and HRP-conjugated secondary antibody. Schematic diagrams of the different forms of EL detected by the
anti-Myc antibody are shown. C,Western blot of EL and EL-EL detected by an antibody against EL. Expression
in HEK293 conditioned media of Myc-tagged EL and EL-EL was detected by Western blot using a rabbit anti-
human EL polyclonal antibody and HRP-conjugated secondary antibody. Schematic diagrams of the different
forms of EL as detected by the anti-EL antibody are shown.
FIGURE 5.Westernblotsof ELandEL-ELunder conditionspromotingdiffer-
ent levels of cleavage. The level of protein expression in HEK293 conditioned
media was detected by Western blot using a mouse anti-Myc monoclonal anti-
body (Ab) and HRP-conjugated secondary antibody. GFP (as negative control),
EL, andEL-ELwereexpressed inHEK293cells under conditionspromotingdiffer-
ent levels of cleavage. HEK293 cells stably expressing profurin prevented EL
cleavage, andHEK293 cells stably expressing PC5a promote the cleavage of EL.
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exponential decay as a function of radiation dose that was
clearly different from the other two. The functional molecular
mass of protein calculated for that preparationwas 79 kDa. The
predicted molecular masses of the protein components of par-
tially cleaved forms are 90,629 and 82,629 Da, respectively
(these are the 108- and 96-kDa forms in Fig. 4A with carbohy-
drate). These data indicate that, after cleavage, one of the
domains can dissociate from the intact monomer, whereas the
other remains with the monomer and the molecule remains
active.
Structural Modeling of EL—Comparative models of EL were
created computationally to assess the feasibility of head-to-tail
homodimer formation with EL and the possible impact of such
a configuration on activity. Presently, no high resolution struc-
tures of EL have been determined, in part due to the marginal
stability of the EL protein under laboratory conditions. There-
fore, comparative modeling was employed to infer likely struc-
tures of the protein. Previously published structures of pancre-
atic lipases from human and horse were used as structural
templates in conjunction withmultiple sequence alignments of
lipase sequences from several different species to generate
three-dimensional models of human EL monomers. After
model refinements using the MODELLER suite, the best scor-
ing EL monomer models were aligned to the structure of the
horse pancreatic lipase, which crystallized as a head-to-tail
dimer (40). The EL dimer model (Fig. 7) aligns well to each
monomer within the horse pancreatic lipase dimer, and the
overall positions of the N terminus, activation lid, hinge, and
C-terminal domains are similar to those of horse pancreatic
lipase. The EL dimer model contains no steric clashes between
monomers at the dimer interface. Within the EL dimer model,
the N-terminal catalytic triad is in proximity (within 30 Å) to
the C-terminal domain of the other monomer.
DISCUSSION
LPL, HL, and EL are members of the triglyceride lipase gene
subfamily involved in plasma lipoprotein metabolism. EL has a
particular tropism for HDL andmodulates HDLmetabolism in
mice and in humans (41, 42). To date, only the three-dimen-
sional structure pancreatic lipase has been resolved by x-ray
crystallography (2). Based on the high amino acid homology
and the conservation of the catalytic triad, LPL, HL, and EL are
assumed to present three-dimensional structures similar to
pancreatic lipase. Both HL and LPL have been shown to be
active in a homodimeric form, using methods varying from
ultracentrifugation, gel filtration, antibody inhibition, to radia-
tion inactivation (18, 21, 23, 24, 26–28, 43). Mutants of LPL
engineered by molecular biology have shown that LPL is active
as a homodimer in a head-to-tail conformation (28–30).
The purpose of this work was to determine the active form of
EL. Initial experiments of immunoprecipitation of media from
co-transfection of constructs encoding EL-myc and EL-FLAG
showed that proteins immunoprecipitated with anti-Myc anti-
body contained both Myc-tagged EL and FLAG-tagged EL.
Thus, there was an interaction between EL-FLAG and EL-myc
proteins, consistent with an oligomerization of EL. However,
when conditioned media from cells expressing either EL-myc
or EL-FLAG were incubated together prior to immunoprecipi-
tation, no evidence of interaction was observed. This suggests
that dimerization occurs intracellularly, before secretion, and
that there is a high affinity, stable interaction between subunits.
Ultracentrifugation studies of other triglyceride lipase family
members suggested that the plasma compartment lipases are
dimers. HumanHLwas shown to have a molecular mass of 121
kDa (43), and similar studies of rat HL showed 113 kDa (26).
Together, these data suggested that HL exists as a dimer. Anal-
ysis of the sedimentation coefficient of bovine LPL yielded a
molecular weight of 96,900, whereas the molecular weight of
the monomer was 48,300 (21). Thus the native LPL enzyme
appears to be a dimer of presumably identical subunits. Simi-
larly, the bovine LPL activity profiles from sedimentation equi-
librium as well as from gel filtration indicated that activity was
FIGURE 6. Radiation inactivation of EL and EL-EL. The loss of triglyceride
lipase activity of EL as a function of radiation dose (megarads) is shown.
Three sources of EL were studied as follows: conditioned medium from
cells expressing myc-His-tagged wild-type EL that was partially cleaved
(, wt(cleaved)), conditioned medium from cells expressing profurin to
produce EL that was uncleaved (, wt(uncleaved)), and conditioned
medium from cells expressing profurin to produce EL-EL that was
uncleaved (, dimer(uncleaved)).
TABLE 1
Triglyceride lipase and phospholipase activities of EL and EL-EL
under conditions promoting different levels of cleavage
Wild-type EL and EL-EL were expressed in HEK293 cells under control conditions
and under conditions promoting different levels of cleavage. HEK293 cells stably
expressing profurin prevent EL cleavage, and HEK293 cells stably expressing PC5a
promote the cleavage of EL. The triglyceride lipase activity (TG activity) and phos-
pholipase activity (PL activity) of each conditionedmediumwere expressed in nano-
moles of free fatty acid product (P) formed/h-ml of conditioned media as source of
lipase. The activity values reported in this table are themean values and the standard
deviations (mean S.D., n 3). The ratio of the triglyceride lipase to phospholipase
activity (TG/PL ratio) represent the substrate specificity of the enzyme. The last
column represents the mean values and the mean  S.D. of the triglyceride/phos-
pholipase ratios across independent experiments (n 5 for HEK 293 cell media and
n 4 each for cellmedia fromHEK293 cells expressing profurin or PC5a). Statistical
analysis was run using an unpaired t test to determine whether the mean of the
triglyceride/phospholipase ratios were significantly different (p  0.05). The trig-
lyceride/phospholipase ratios of EL-EL and wild-type EL were not statistically dif-
ferent experimentally whatever the cell types used for the transfection.
293 cells Lipases TG activity PL activity TG/PL ratio(mean S.D.)
nmol P/h/ml nmol P/h/ml
PC5a EL 172.5 8.4 92.7 7.4 1.92 0.12
EL-EL 425.5 8.6 173.1 10.6 1.56 0.62
EL 265.9 3.8 172.4 1.1 1.56 0.24
EL-EL 484.9 20.2 226.0 11.3 1.46 0.57
Profurin EL 445.2 10.5 306.5 79.1 1.72 0.24
EL-EL 673.5 22.1 313.1 4.5 1.79 0.58
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associated almost exclusively with the dimer fraction (24).
Sucrose density gradient centrifugation was also used to deter-
mine that monomeric LPL refolded in the presence of calcium
becomes dimeric (44).
A complicating issue in determining the functional size of
catalytically active EL relates to its susceptibility to proteolytic
cleavage by proprotein convertases (19, 20). One can predict
that, upon cleavage of a dimeric uncleaved EL, a number of
possible forms might be obtained (Fig. 4A) and that some of
these partially cleaved forms could potentially retain catalytic
activity. The lack of enzymatic activity of the N-terminal por-
tion of EL (14) indicates that an interactionwith the C-terminal
domain is essential to activity. Even if EL is active as a dimer in
a head-to-tail conformation, other intermediate forms could
potentially also be active as long as an intact active site is pres-
ent and the contribution of theC-terminal domain is preserved.
Using classic sucrose density ultracentrifugation methods, we
compared the mobility of wild-type EL to that of several pro-
teins of knownmolecularmasses and calculated that themolec-
ular mass of wild-type EL was 94.5 kDa. As this preparation of
EL was made in HEK293 cells, which also secrete proprotein
convertases, EL in the preparation was at least partially cleaved.
The estimated molecular mass is consistent with either of the
partially cleaved forms (Fig. 4A) where an intact N-terminal or
C-terminal domain remains associated with an intact mono-
mer. These data suggest that one or both of these partially
cleaved forms is active.
We then prepared EL in a head-to-tail homodimer using
methods similar to those used by Wong et al. (28), wherein
we made a construct encoding
such a dimer covalently linked by
an 8-amino acid hinge region (Fig.
1). The construct also contained a
myc-His tag to allow estimation of
expression. The dimer construct
expressed nearly as well as the wild
type. However, the triglyceride and
phospholipase activities of the
dimer preparations were consis-
tently higher that those of the wild
type. The ratios of triglyceride to
phospholipase activities were essen-
tially unchanged, indicating that the
covalent linkage of the dimer had no
effect on substrate specificity. To
determine the effect of cleavage on
activity, we compared activity from
wild type to that of the dimer in con-
ditions of normal, high, or low activ-
ity of proprotein convertases. As
shown in Table 1, activity was high-
est in the absence of cleavage for
both wild-type and dimeric EL and
lowest for both in the presence of
the highest degree of cleavage.
Interestingly, the dimeric form
appeared to bemore resistant to loss
of activity than the wild type. This
may be due to a resistance to cleavage by proprotein converta-
ses or to the fact that the covalent hinge between theC terminus
of the original first EL monomer keeps the N terminus of the
second EL monomer attached so that an active molecule is
retained. Even with a high degree of cleavage (Fig. 5) of EL
prepared in cells expressing PC5, robustly detectable activity
remains (Table 1), suggesting that fully cleaved N- and C-ter-
minal fragments can remain together and maintain an active
site.
The functional size of EL was also examined using radiation
inactivation to determine the size of the active unit. The radia-
tion inactivation method was developed to determine the size
of enzymes (45) and has been previously used to determine the
functional molecularmass of both LPL (23, 46) andHL (25, 44).
For bovine milk LPL, the combined data of radiation inactiva-
tion under a number of different conditions yielded a functional
size of 72 kDa for the unglycosylated protein, which is close to
that expected for a dimer, 77 kDa (23). For rat LPL the func-
tional molecular mass was calculated to be 127 kDa, again the
unglycosylated size (46), consistent with a dimer. Thus the
smallest unit required for enzyme function constitutes a dimer
in the case of LPL. There is some discrepancy in the literature
with regard to the functional unit of HL. When recombinant
human HL was subjected to radiation inactivation, the size of
functional HL was calculated to be 109 kDa (unglycosylated),
the size of a homodimer (43). An examination of rat HL from
liver, adrenal gland, and ovaries showed that the liver enzyme
had a functional molecular mass of 63 kDa (monomeric), but
the enzymes from the adrenals and ovaries both showed func-
FIGURE 7.Molecularmodel of the EL dimer. Top view of the human endothelial lipase dimermodel is shown.
The N-terminal “head” domains are shaded in blue; the C-terminal “tail” domains are shaded in red. The activa-
tion lid is colored green. The three catalytic residues, serine 169, aspartic acid 193, and histidine 274 are
rendered in a space-filling format and located under the activation lid. A collection of exposed hydrophobic
residues,Met-351, Leu-382, Pro-383, Ile-386, Val-387, Phe-398, Leu-399, Val-400, Pro-437, Pro-440, andGly-441,
is highlighted in pink on monomer 1. Monomer 2 is rendered so as to reveal the N- and C-terminal domains,
hinge, and secondary structure.
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tional molecular masses of 117 kDa (dimeric) (26). Unlike the
sucrose density analysis, radiation inactivation is not influenced
by glycosylation and might therefore be a more accurate
method in the case of glycosylated protein such as EL. Another
advantage to the radiation inactivation is that it is a method for
determining the functional size of a protein without the need of
prior purification. Uncleaved preparations of wild-type EL and
EL-EL gave similar functional molecular mass estimates, con-
sistent with the concept that EL is active as a homodimer and
are in agreement with the data previously generated for LPL
(23, 46) and HL (25, 43). Interestingly, cleavage of only one
“side” of the homodimer results in an intermediate size form
(Fig. 4A) that is still active, although less so than the full
homodimer.
In an elegant model of LPL (47), a head-to-tail conformation
was proposedwhere themonomers associate side-by-side. This
conformation has enough space for the lid to move freely to
enable a conformational change upon substrate binding (47).
Based on this, we developed a similar model for EL (Fig. 7). Our
EL dimer model contains no steric clashes between monomers
at the dimer interface. Within this model, the N-terminal cata-
lytic triad of one-half of the dimer is in close proximity to the
C-terminal domain of the other half. This model suggests how
the C-terminal domain could affect substrate specificity by
playing a role in positioning the substrate in proximity to the
catalytic triad of the other half of the dimer across the dimer
interface. In contrast, in a monomer model, the C-terminal
domain is almost twice as far from the catalytic triad (60 Å).
Indeed in the EL dimer model, a hydrophobic collection of
amino acids (Met-351, Leu-382, Pro-383, Ile-386, Val-387, Phe-
398, Leu-399, Val-400, Pro-437, Pro-440, and Gly-441) in the
C-terminal domain is in proximity to the catalytic triad (under
the activation lid) of the N-terminal domain of the other mon-
omer (Fig. 7). Furthermore, there is ample volume for the acti-
vation lids of eachmonomer to open into themiddle part of the
dimer interface, and therefore head-to-tail packing could help
stabilize the opening of the lid through ionic or hydrophobic
interactions on the surface of the opposingmonomer, similar to
the observations of Kobayashi et al. (29) with their computa-
tional model of LPL. These observations, in conjunction with
the biochemical activity data, suggest that head-to-tail dimer-
ization of ELmay help position the C-terminal domain, impor-
tant for substrate specificity, in close proximity to the catalytic
region of the enzyme while in turn stabilizing the movement of
the activation lid.
In conclusion, HL and LPL have been shown using a variety
of methods to be active in a homodimeric form and, at least for
LPL, in a head-to-tail conformation.We comprehensively stud-
ied EL functional size using a variety of similarmethods, includ-
ing ultracentrifugation, radiation inactivation, covalent EL
homodimer, immunoprecipitation, and molecular modeling.
Our data are wholly consistent with a model in which EL oli-
gomerizes into a homodimer that is active in a head-to-tail con-
formation. Only the full length of EL is present on the cell sur-
face (data not shown), and it is conceivable that dimerization of
EL allows its optimal activity against and interaction with its
substrates, HDL, on the endothelial surface. Furthermore, EL is
proteolytically cleaved in the hinge region by proprotein con-
vertases, resulting in partially cleaved dimeric forms of EL that
retain some activity and could have particular physiologic roles.
Because EL is a pharmacologic target for inhibition as a strategy
to raise HDL cholesterol levels, detailed structural information
regarding the active forms of EL could be important to the
optimal design of EL inhibitors.
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